Discover how Chemycal PRO helps you boosting your regulatory monitoring:
Subject matter
A decision taken by the European Chemicals Agency (the ‘Agency’) pursuant to Article 40 of the REACH Regulation, in accordance with the procedure laid down in Articles 50 and 51 of the REACH Regulation
Contested Decision
TPE-D-2114538916-37-01/F of 20 January 2021
Background to the appealThe Appellant’s registration dossier for sodium hydrogen N-(1-oxotetradecyl)-L-glutamate (EC number 253-981-4, CAS number 38517-37-2) included a proposal to perform a pre-natal developmental toxicity study (EU B.31./OECD test guideline (‘TG’) 414), using an analogue substance, instead of a screening study (OECD TG 421/422).
On 20 January 2021, the Agency adopted the Contested Decision rejecting the Appellant’s testing proposal.
CONTINUE READING ON: echa.europa.eu2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions